C.Q. Pharmaceutical Holding Co., Ltd.

Shenzhen Stock Exchange 000950.SZ

C.Q. Pharmaceutical Holding Co., Ltd. EBIT for the year ending December 31, 2023: USD 331.25 M

C.Q. Pharmaceutical Holding Co., Ltd. EBIT is USD 331.25 M for the year ending December 31, 2023, a -10.80% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

C.Q. Pharmaceutical Holding Co., Ltd. EBIT for the year ending December 31, 2022 was USD 371.36 M, a -10.61% change year over year.
C.Q. Pharmaceutical Holding Co., Ltd. EBIT for the year ending December 31, 2021 was USD 415.43 M, a 34.41% change year over year.
C.Q. Pharmaceutical Holding Co., Ltd. EBIT for the year ending December 31, 2020 was USD 309.09 M, a 41.52% change year over year.
C.Q. Pharmaceutical Holding Co., Ltd. EBIT for the year ending December 31, 2019 was USD 218.40 M, a 82.87% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

Shenzhen Stock Exchange: 000950.SZ

C.Q. Pharmaceutical Holding Co., Ltd.

CEO	Mr. Wei Liu
IPO Date	Sept. 16, 1999
Location	China
Headquarters	No 1, Datong Road
Employees	14,485
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

C.Q. Pharmaceutical Holding Co., Ltd. distributes pharmaceutical products. Chongqing Medicines Co., Ltd. was formerly known as Southwest Branch of China Medicine Company. The company was founded in 1950 and is based in Chongqing, China. C.Q. Pharmaceutical Holding Co., Ltd. develops, manufactures, and distributes pharmaceuticals. The company is based in Chongqing, China. C.Q. Pharmaceutical Holding Co., Ltd. operates as a subsidiary of Chongqing Chemical & Pharmaceutical Holding Group Company

Key trends

Past 5 years